IVIG shows no impact on VTE risk in dermatomyositis patientsMay 11, 2023Autoimmune DiseasesRare Diseases
Childhood lupus severity linked to social determinants of healthApril 4, 2023PediatricsRare DiseasesAutoimmune Diseases
Biosimilars and patients: Discussions should address safety, cost, and anxiety about changeMarch 30, 2023Business of MedicinePsoriatic ArthritisPediatricsRare DiseasesPsoriasisAutoimmune Diseases
Anifrolumab shows promise in refractory discoid lupus erythematosusMarch 27, 2023Autoimmune DiseasesMedical Dermatology
CT results in myositis inform cancer screening strategiesMarch 24, 2023Autoimmune DiseasesRare Diseases
Novel therapy shows promise for treating skin-predominant dermatomyositisMarch 21, 2023Autoimmune DiseasesMedical Dermatology
Experts share real-world experience prescribing voclosporin, belimumab for lupus nephritisMarch 8, 2023Autoimmune Diseases
Autoantibodies signal reduced cancer risk in dermatomyositisFebruary 22, 2023Autoimmune DiseasesRare Diseases
New influx of Humira biosimilars may not drive immediate changeFebruary 22, 2023Autoimmune DiseasesPsoriasisPsoriatic ArthritisBusiness of Medicine
New tool better estimates cardiovascular risk in people with lupusFebruary 16, 2023Autoimmune Diseases
Health plans get very poor scores for access to autoimmune drugsFebruary 14, 2023Business of MedicinePsoriatic ArthritisPsoriasisAutoimmune Diseases
